News Archive
Filter by Division
Filter by Categories
MCP Student Sahiti Marella shares her journey to becoming grant funded
March 8, 2023 / Molecular And Genomic PathologyThe Department of Pathology offers the Molecular and Cellular Pathology Graduate Program (MCP) for students who are interested in translational research – the step between basic science research and clinical care, the “bench-to-bedside” transition. Sahiti Marella is a graduate student in the MCP who was recently awarded her first F31 grant. This is an NIH-funded predoctoral grant that provides awardees with a monthly stipend to support tuition and fees, and funds for training-related costs while they conduct their PhD research project, for up to five-years of funding.
Rogel Researchers Receive $4M Through Prostate Cancer Foundations Inaugural TACTICAL Awards Program
January 10, 2023 / MctpThe University of Michigan Rogel Cancer Center researchers received one of the Prostate Cancer Foundation’s four inaugural Class of 2022 TACTICAL (Therapy ACceleration To Intercept Cancer Lethality) Award. This $30 million program will support cross-disciplinary pioneering research toward the goal of developing 21st Century therapies for the most life-threatening form of prostate cancer [...]
Careers in Pathology: Research Administration
March 21, 2022 / ResearchMeet the members of the Research Administration team within the Department.
Prostate Cancer Regulator Plays Role in COVID-19, Providing a Promising Treatment Lead
December 22, 2020 / Cancer ResearchClinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus. wo proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, MD, PhD. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers [...]
Marcin Cieslik Receives Award from Bristol-Myers Squibb
March 11, 2020 / AwardMarcin Cieslik, Assistant Professor of Pathology and Computational Medicine and Bioinformatics and member of the Michigan Center for Translational Pathology (MCTP), received an award from Bristol-Myers Squibb (BMS) for the project entitled, “Identification of novel therapeutic vulnerabilities across immunophenotypes of refractory and metastatic tumors.” This award provides two years of funding.
Nicholas Lukacs, PhD, Receives an Outstanding Investigator Award
March 5, 2020 / FacultyNicholas Lukacs, PhD, The Godfrey Dorr Stobbe Professor of Pathology, received an Outstanding Investigator Award (OIA or an R35) from the National Heart, Lung, and Blood Institute (NHLBI) entitled, “Viral and allergen-driven immunity in chronic lung disease.” This award will provide 7 years of funding. [...]
Dr. Chan Chung Receives Two Grants to Study Brain Cancers
January 9, 2020 / GrantsChan Chung, PhD, received two grants in funding from the ChadTough Foundation and Defeat DIPG foundation ($150,000) and the Robert Connor Dawes CERN Pediatric Fellowship ($100,000). [...]
Updated NIH Policy Statement Emphasizes "Other Support" Reporting
December 20, 2019 / ResearchAll faculty who serve as the Principal Investigator or one of the key personnel on an NIH award or pending proposal are required to review their new guidance and address the two parts below, as appropriate, by January 20, 2020 [...]
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
